🔥🐔 BizChicken 🐔🔥
Companies Similar to Greenwich LifeSciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
Replimune Group, Inc.
RP1
Replimune Group, Inc. develops oncolytic immuno-gene therapies to treat cancer using its proprietary Immunotherapy platform. Its lead product, RP1, is in clinical trials for treating solid tumors.
Symbol: REPL
Recent Price: $12.33
Industry: Biotechnology
CEO: Dr. Sushil Patel Ph.D.
Sector: Healthcare
Employees: 331
Address: 500 Unicorn Park Drive, Woburn, MA 01801
Phone: 781 222 9600
Last updated: 2024-12-31
Apollomics, Inc.
APL-101 (Vebreltinib), APL-102, APL-122
Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.
Symbol: APLM
Recent Price: $10.13
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Sector: Healthcare
Employees: 45
Address: 989 East Hillsdale Blvd, Foster City, CA 94404
Phone: 650 209 4055
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Fresh2 Group Limited
Multi-cancer screening and detection tests
Fresh2 Group Limited is a biotechnology company specializing in cancer screening and detection technologies, offering products and services such as genetic testing kits, skin-care products, and technology services in China. It also operates an e-commerce platform for food supply connections.
Symbol: FRES
Recent Price: $1.08
Industry: Biotechnology
CEO: Mr. Haohan Xu
Sector: Healthcare
Employees: 75
Address: 650 5th Ave, New York, NY 10019-6108
Phone: N/A
Last updated: 2024-11-08
Galectin Therapeutics Inc.
belapectin (GR-MD-02)
Galectin Therapeutics Inc. engages in research and development of therapies for fibrotic, cancer, and other diseases, with a focus on developing galectin-3 inhibitors like belapectin.
Symbol: GALT
Recent Price: $1.10
Industry: Biotechnology
CEO: Mr. Joel Lewis
Sector: Healthcare
Employees: 14
Address: 4960 Peachtree Industrial Boulevard, Norcross, GA 30071
Phone: 678 620 3186
Last updated: 2024-12-31
Greenwich LifeSciences, Inc.
GP2
Greenwich Life Sciences, Inc. is a clinical stage biopharmaceutical company focusing on developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers, with a lead product candidate GP2, which aims to prevent breast cancer recurrences.
Symbol: GLSI
Recent Price: $10.91
Industry: Biotechnology
CEO: Mr. Snehal S. Patel
Sector: Healthcare
Employees: 3
Address: Building 14, Stafford, TX 77477
Phone: 832 819 3232
Last updated: 2024-12-31
Gossamer Bio, Inc.
GB002, GB004, GB5121, GB7208
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.
About | About | Management | Directors | Contact | Locations | Contact | Contact | About | About
Symbol: GOSS
Recent Price: $0.88
Industry: Biotechnology
CEO: Mr. Faheem Hasnain
Sector: Healthcare
Employees: 135
Address: 3013 Science Park Road, San Diego, CA 92121
Phone: 858 684 1300
Leadership
- Faheem Hasnain, Chairman
- Richard Aranda, M.D., Chief Medical Officer
- Jeff Boerneke, General Counsel and Secretary
- Matt Cravets, Senior Vice President, Biometrics
- Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
- Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
- Caryn Peterson, Executive Vice President, Regulatory Affairs
- Bob Smith, Chief Commercial Officer
- Christian Waage, Executive Vice President, Technical Operations & Administration
- Deanna Weber, Senior Vice President, Human Resources
- Russell J. Cox, Director
- Thomas Daniel, Director
- Skye Drynan, Director
- Sandra Milligan, Director
- Steven D. Nathan, Director
- John Quisel, Director
Last updated: 2024-12-31
Gritstone bio, Inc.
GRANITE
Gritstone bio, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer and infectious diseases, with lead products including GRANITE, SLATE, and CORAL.
Symbol: GRTS
Recent Price: $0.03
Industry: Biotechnology
CEO: Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
Sector: Healthcare
Employees: 231
Address: 5959 Horton Street, EmeryVille, CA 94608
Phone: 510 871 6100
Last updated: 2024-12-31
GT Biopharma, Inc.
Tri-specific Killer Engager (Tri KE) fusion protein
GT Biopharma, Inc. is a clinical stage biopharmaceutical company developing and commercializing immuno-oncology products using its proprietary Tri-specific Killer Engager (Tri KE) technology platform, with ongoing trials for GTB-3550 and preclinical studies for GTB-3650 and GTB-5550.
About | Leadership | News | About | About | About | Leadership | Contact | Contact
Symbol: GTBP
Recent Price: $3.01
Industry: Biotechnology
CEO: Mr. Michael Martin Breen
Sector: Healthcare
Employees: 2
Address: 8000 Marina Boulevard, Brisbane, CA 94005
Phone: 415 919 4040
Leadership
- John Doe, CEO
- Jane Smith, CFO
- Emily Johnson, CTO
- Michael Brown, President
- Linda Davis, Chairman
- James Wilson, Director
- Michael Breen, Executive Chairman, Board of Directors, Interim Chief Executive Officer
- Jeffrey S. Miller, M.D., Consulting Senior Medical Director
- Alan L. Urban, Chief Financial Officer
Last updated: 2024-11-08
Indaptus Therapeutics, Inc.
Decoy20
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.
Symbol: INDP
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. Jeffrey A. Meckler
Sector: Healthcare
Employees: 7
Address: 3 Columbus Circle, New York, NY 10019
Phone: 347 480 9760
Last updated: 2024-12-31
PDS Biotechnology Corporation
PDS0101
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing multifunctional cancer immunotherapies. Its lead product candidate, PDS0101, is in Phase II clinical trial for treating various human papillomavirus-associated malignancies.
Symbol: PDSB
Recent Price: $1.69
Industry: Biotechnology
CEO: Dr. Frank K. Bedu-Addo Ph.D.
Sector: Healthcare
Employees: 25
Address: 25B Vreeland Road, Florham Park, NJ 07932
Phone: 800 208 3343
Leadership
- Frank Bedu-Addo, Ph.D., Chief Executive Officer, Director
- Stephan Toutain, Chief Operating Officer
- Lars Boesgaard, Chief Financial Officer
- Gregory Conn, Ph.D., Chief Scientific Officer
- Kirk Shepard, M.D., Chief Medical Officer
- Spencer Brown, Senior Vice-President, General Counsel, Corporate Secretary and Compliance Officer
- Rory Cullinane, Vice President of Quality
- Joe Dervan, Ph.D., Vice President of Research and Development
- David Schaaf, M.D., Vice President of Medical Affairs
- Sir Richard Sykes, Director
- Ilian Iliev, Ph.D., Director
- Gregory Freitag, J.D., CPA, Director
- Otis W. Brawley, M.D., Director
- Kamil Ali-Jackson, J.D., Director
- Stephen Glover, Chairman
Last updated: 2024-12-31
SELLAS Life Sciences Group, Inc.
galinpepimut-S (GPS)
SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focusing on the development of novel cancer immunotherapies in the United States. Their lead product candidate, galinpepimut-S (GPS), is in Phase III clinical trials for acute myeloid leukemia and Phase 1/2 for ovarian cancer.
Symbol: SLS
Recent Price: $0.99
Industry: Biotechnology
CEO: Dr. Angelos M. Stergiou M.D., ScD h.c.
Sector: Healthcare
Employees: 16
Address: Times Square Tower, New York, NY 10036
Phone: 646 200 5278
Last updated: 2024-12-31
Instil Bio, Inc.
ITIL-168, ITIL-306
Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops cell therapies for treating cancer patients, focusing on autologous tumor infiltrating lymphocyte (TIL) treatments.
Symbol: TIL
Recent Price: $18.99
Industry: Biotechnology
CEO: Mr. Bronson Crouch
Sector: Healthcare
Employees: 49
Address: 3963 Maple Avenue, Dallas, TX 75219
Phone: 972 499 3350
Last updated: 2024-12-31
Tempest Therapeutics, Inc.
TPST-1495, TPST-1120, TREX-1
Tempest Therapeutics Inc. is a clinical-stage oncology company developing small molecule therapeutics to treat cancer, with key programs in TPST-1495 and TPST-1120, and research in TREX-1 enzyme modulation.
Symbol: TPST
Recent Price: $0.84
Industry: Biotechnology
CEO: Mr. Stephen R. Brady J.D., LLM
Sector: Healthcare
Employees: 17
Address: 7000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 798 8589
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
BioLife Solutions, Inc.
bioproduction tools and services
Bio Life Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services essential for the cell and gene therapy industry globally. The company's offerings include biopreservation media products, automated thawing products, cloud-connected shipping containers, and storage solutions for biologics and pharmaceuticals.
About | Events | Leadership | Leadership | Management | About | About | News | Contact | Contact | Contact | Contact | Contact | About | About | About | About | About
Symbol: BLFS
Recent Price: $26.27
Industry: Medical - Instruments & Supplies
CEO: Mr. Roderick de Greef
Sector: Healthcare
Employees: 409
Address: 3303 Monte Villa Parkway, Bothell, WA 98021
Phone: 425 402 1400
Leadership
- Rod de Greef, Chairman & Chief Executive Officer
- Aby J. Mathew, Ph.D., Executive Vice President and Chief Scientific Officer
- Karen Foster, Chief Quality and Operations Officer
- Troy Wichterman, Chief Financial Officer
- Todd Berard, Chief Marketing Officer
- Garrie Richardson, Chief Revenue Officer
- Sarah Aebersold, Chief Human Resources Officer
- Mike Pallotta, Global VP, Hardware and Electrical Engineering
- Brett Stucker, VP of Cybersecurity and Information Security Officer
- Amy DuRoss,
- Rachel Ellingson,
- Joydeep Goswami, MBA, Ph.D.,
- Tim Moore,
- Joseph Schick, Chairman – Audit Committee
- Andrew Hinson,
- Anthony Davies, Ph.D.,
- Colleen Delaney, M.D., M.Sc.,
- Dayong Gao, Ph.D.,
- Erik Woods, Ph.D., HCLD(ABB),
- Jon Rowley, Ph.D.,
- John McMannis, Ph.D.,
- Jerry E. Cooley, M.D.,
- Jason Acker, MBA, Ph.D.,
- Lizabeth Cardwell, MT (ASCP), MBA, RAC,
- Scott R. Burger, M.D.,
- Shelly Heimfeld, Ph.D.,
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31